Alzheimer’s sheds light into the final frontier that offers much more than answering the question of the origin of disease, but the origin of mankind as a species. The difference and lack of difference in man though scientifically is drastically unequal, but hold identical impact on the focus and progression of humanity. The argument of what race is reaches its apex as race is molded into a scientific hypothesis that comes to heads with genetic universality that upon isolation breeds genomics. Do our genetics define our humanity, or do our genomics implicate race to be the source of what causes diseases like Alzheimer’s. The results, though polarized, garner the same conclusion when one takes a step back, that disease is caused by systematic …show more content…
Bias can occur in the planning, data collection, analysis, and publication phases of research. Understanding research bias allows readers to critically and independently review the scientific literature and avoid treatments which are suboptimal or potentially harmful. A thorough understanding of bias and how it affects study results is essential for the practice of evidence-based medicine. Contextually, the bias in the research practices to understand Alzheimer’s and moreover the deviating conclusions garnered due to the variances in research practices allude to a greater issue present. Specifically, the idea of race as a scientific category is a blatantly erroneous conclusion that has arisen due to the biased practices in research that continues to be perpetuated in not just the research for Alzheimer’s but in the scientific field. For the idea of genetics and genomics to perpetuate the resurfacing of race is a testament of how the subjectivity of research augments subjective conclusions that correlate with the erroneous conduction of research in
In times past many people thought that memory loss was a normal occurrence for elderly people. This thinking was major reason for why Alzheimer’s disease was not caught until very later in the stages. Alzheimer’s disease is not a normal part of aging. After heart disease, cancer, and strokes, Alzheimer’s is the most common cause of death in adults in the Western world. “It is estimated that 4.5 million Americans over the age of 65 are affected with this condition. After the age of 65, the incidence of the disease doubles every five years and, by age 85, it will affect nearly half of the population” (Robinson).
Alzheimer’s disease is a common problem in today’s society and within the older population this disease makes up the largest form of dementia. Although it is a problem in mainly older people, this disease can still occur in the younger population also. People in their 30s-50s can be diagnosed with this disease, even though it is not as common as people in their 60s-90s. The number of people with Alzheimer’s in the U.S. is close to five million and is expected to double within the next 30 years. With our modern medicine and advancements one would think a cure would be available, however, getting to the cause of the disease is a major factor. The cause of Alzheimer’s disease is one that is very debatable and questionable and most likely is a result of multiple factors rather than one. The main issue with finding the cause is because this disease affects the brain and can
The disease called Alzheimer’s is the fourth leading cause of death in the United States (Weiner, 1987). It is estimated that the elderly population will double between now and 2030. During this period, the number of elderly will grow by an average of 2.8% annually (U.S. Census Bureau, 2001). By 2050, the number of people with Alzheimer’s is estimated to range from 11.3 million to 16 million (Alzheimer’s Association, 2005). These startling numbers should prompt an examination into one of the leading causes of death among this group of people. Understanding what Alzheimer’s is and the known causes of the disease are a good starting point. For those who have aging family members, knowing the risk factors and warning
Alzheimer’s Disease is a disease of the future. With the growing aged population, this disease, which affects primarily the elderly, will become of increasing relevance to the medical profession. Also, the high frequency of Alzheimer’s, and the high cost in labor, money, and material of caring for its victims shall put considerable burden on the society as a whole. Here, however, these issues are not going to be debated. Instead the pathology of Alzheimer’s will be reviewed to the extent it is known today.
Alzheimer’s Disease is an irreversible, genetically linked illness. This disease was chosen for the topic of this essay under the consideration that in many families the illness can be incredibly tragic, passing down for generations without mercy. It is not rare to encounter families in which each member is afflicted with a form, mild or severe, of Alzheimer’s. The disease is a progressive brain disease which comes in two separate types: Early-Onset Alzheimer’s Disease and Late-Onset Alzheimer’s Disease. These will be discussed in full later on in the paper.
The call came at 9:05 p.m. on January 20, 2004. Mom had just finished telling the news about the girl's grandfather. He had Alzheimer's Disease and was not doing well at all. The ruling was that he probably would not make it through the night. She knew exactly what the news was the moment her mom said, "No." After the news came, the decision was made they would leave the next day to attend the funeral.
This is relevant in developing and developed countries as many developed countries are now multicultural with an estimated one fifth of the world's population being a migrant. [109] Two studies on UK based South Asians demonstrated lack of awareness of dementia as an illness, and perceptions about dementia being attributed to social stressors and spiritual wrong-doing. There were also strong views on self-reliance and family responsibility to cure the patient. This could present barriers to help-seeking via health professionals or community services. [109, 110] Racial influence on the ability to recognize cognitive impairment was demonstrated in a US study comparing informant's report of cognitive decline between blacks and whites. [111] There is potential cultural, language and racial bias in test instruments with development of race specific norms which may result in false negatives and lead to racial disparities in access to anti-dementia drugs and services. [111,
Throughout history there have been reports of decreased memory and mental deterioration that accompanied old age. Alzheimer’s disease (AD) was named after Dr. Alois Alzheimer who described the symptoms in a woman in Germany in the 1907 but it was not until the 1970’s that AD was considered to be a major disorder and AD continues to be a major health concern worldwide (Reger, 2002).
It is said that Alzheimer have a higher risk among African Americans than white Americans (Fortune 93). This disease is prevalent up to 14% or even 100% among aging African Americans due to higher risk factors. It is believe that the lack of education of this degenerative disease cause the most damage as minorities
The stigma associated with accessing mental health services, as well as African Americans’ cultural beliefs about aging presents another discrepancy (Clark et al., 2005). Hence in the African American community the disease is rarely identified. The fact that African Americans’ are also underrepresented in studies that examine substantial factors, including environmental, molecular, and pathophysiological factors compounds the risk factor. Subsequently limiting the accuracy of research studies targeted to address the needs of individuals with dementia related Alzheimer’s disease (Holston, 2005). According to the 2005 Clark et al., study, screening for Alzheimer’s disease is a good intervention from a public health perspective; however it is rarely done or required on a routine basis which also impedes timely diagnosis. Limited access to adequate health care and other ethnic disparities will continue to be a risk factor for African American women age sixty five and
Alzheimer’s disease is one of the most devastating degenerative diseases affecting the American population. It is one form of dementia. Dementia is a group of conditions characterized by impairment of at least two brain functions, such as memory loss and judgment. Symptoms include forgetfulness, limited social skills, and thinking abilities so impaired that it interferes with daily functioning. Alzheimer has very few treatment options even though it is increasing globally. Recently environmental exposures have been studied as a catalyst for the onset of the disease. This paper will review how genetic, biological, medication and sociological factors can increase the risk of Alzheimer onset.
In 1901, a fifty one year old woman named Frau Auguste D. was admitted to a psychiatric hospital in Frankfurt, Germany. She had an unusual bunch of symptoms. While she had no history of prior psychiatric illness, her husband had noticed that Frau D. was becoming increasing paranoid, hallucinatory, agitated, disoriented, and having increasing difficulties with language functions and memory.
The Journal of the American Medical Association reports the latest break through in the study of gene causing Alzheimer’s has pointed to two genes, chromosomes 2 and 19 that cause the disease (7). The article also points out another gene, A polipoprotein E-e4, is also linked to Alzheimer’s disease. According to the Journal of Alzheimer’s disease, Jose Vina and Ana Lloret writes that women are at higher risk of Alzheimer’s due
Alzheimer's Disease is a condition that affects 50% of the population over the age of eighty five, which equals four million Americans each year. It is becoming an important and high-profile issue in today's society for everyone. There are rapid advancements being made in the fight against this disease now more than ever, and the purpose of this essay is to educate the public on the background as well as the new discoveries. There are many new drugs that are being tested and studied every day which slow down, and may even halt the progress of the disease.
Although Alzheimer’s disease (henceforth: AD) has been around since the 19th century or possibly even earlier and was at a point in time classified as senile dementia, it wasn’t until 1906 following Dr. Alois Alzheimer’s encounter with Auguste Deter at a Frankfurt asylum that the name of the disease was finally coined. Since then, major developments relating to the disease has taken place. In our report, we addressed some of the areas of the history, contemporary and prospects of the disease.